The renoprotective effect of once‐weekly GLP‐1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67)
暂无分享,去创建一个
H. Yokoyama | Y. Kurihara | H. Maegawa | K. Yamazaki | I. Yokota | M. Iwamoto | S. Taneda | K. Okada | N. Manda | Yasushi Ishigaki | Ken-Ichi Tsuchida | Kazufumi Okada | Masahiro Iwamoto